Mason & Associates Inc Moderna, Inc. Transaction History

Mason & Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	BUY	$118.07 - $194.18 $354 - $582	3 Added 0.08%	3,929 $465,000
Q2 2022 Jul 26, 2022	SELL	$117.13 - $176.59 $39,121 - $58,981	-334 Reduced 7.84%	3,926 $561,000
Q1 2022 Apr 19, 2022	SELL	$126.46 - $235.05 $63,482 - $117,995	-502 Reduced 10.54%	4,260 $734,000
Q4 2021 Mar 18, 2022	BUY	$225.82 - $368.51 $1.08 Million - $1.75 Million	4,762 New	4,762 $1.21 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Mason & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Mason & Associates Inc with notifications on news.